BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1566 related articles for article (PubMed ID: 17536106)

  • 21. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus.
    Demidchik YE; Demidchik EP; Reiners C; Biko J; Mine M; Saenko VA; Yamashita S
    Ann Surg; 2006 Apr; 243(4):525-32. PubMed ID: 16552205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiated thyroid carcinoma in a juvenile patient.
    Khan MU; Nawaz MK; Saadullah M; Syed AA; Hussain R; Azhar R; Shah MA
    Clin Nucl Med; 2008 May; 33(5):319-20. PubMed ID: 18431142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution.
    Dardas M; Abboud M; Salti I; Sabri A; Shoucair M; Saleh M; Azar S; Rodriguez-Galindo C; Muwakkit S
    Pediatr Hematol Oncol; 2009 Sep; 26(6):439-47. PubMed ID: 19657994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of lymph node status in papillary and follicular thyroid gland carcinoma for the nuclear medicine physician].
    Farahati J; Mörtl M; Reiners C
    Zentralbl Chir; 2000; 125(10):830-4. PubMed ID: 11098578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation].
    Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL
    Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors].
    Chen FJ; Li QL; Zeng ZY; Song M; Yang AK; Zhang Q
    Ai Zheng; 2004 Nov; 23(11):1311-6. PubMed ID: 15522180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients.
    Pelizzo MR; Boschin IM; Toniato A; Piotto A; Pagetta C; Gross MD; Al-Nahhas A; Rubello D
    Clin Nucl Med; 2007 Jun; 32(6):440-4. PubMed ID: 17515749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting outcome and directing therapy for papillary thyroid carcinoma.
    Kim S; Wei JP; Braveman JM; Brams DM
    Arch Surg; 2004 Apr; 139(4):390-4; discussion 393-4. PubMed ID: 15078706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
    Brierley J; Tsang R; Panzarella T; Bana N
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.
    Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Yuen KT; Law CC; Lau WH
    Cancer; 2002 Aug; 95(3):488-98. PubMed ID: 12209740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The survival rate of patients with a differentiated thyroid carcinoma without primary percutaneous irradiation of the neck area].
    Saur HB; Lerch H; Schober O
    Strahlenther Onkol; 1996 Jun; 172(6):306-11. PubMed ID: 8677502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of childhood and adolescent thyroid carcinoma: long-term follow-up and clinical characteristics.
    Okada T; Sasaki F; Takahashi H; Taguchi K; Takahashi M; Watanabe K; Itoh T; Ota S; Todo S
    Eur J Pediatr Surg; 2006 Feb; 16(1):8-13. PubMed ID: 16544219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term course in differentiated thyroid gland carcinoma].
    Rösler H; Birrer A; Lüscher D; Kinser J
    Schweiz Med Wochenschr; 1992 Nov; 122(48):1843-57. PubMed ID: 1462145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.